Display Settings:

Format

Send to:

Choose Destination

    Neurosci Lett. 1984 Jan 27;44(1):37-42.

    The basal nucleus of Meynert in patients with progressive supranuclear palsy.

    Tagliavini F, Pilleri G, Bouras C, Constantinidis J.

    The neuronal number and nucleolar volume of the magnocellular population of the basal nucleus of Meynert in 6 patients with progressive supranuclear palsy (PSP) - one associated with Alzheimer's disease - were compared with those of 5 controls. In the 5 typical PSP cases, an age-dependent neuronal loss was demonstrated ranging from 12.6% to 54.1%. In the PSP-Alzheimer patient, the loss of cells amounted to 73.8% and the surviving neurons exhibited a reduction in the nucleolar volume, suggesting a reduced protein synthetic capability. The involvement of the basal nucleus is therefore a usual anatomical feature of PSP. The damage is less severe than generally observed in Alzheimer's disease and biochemical studies are required to state whether this is accompanied by a substantial cholinergic deficit.

    PMID: 6717850 [PubMed - indexed for MEDLINE]

    Supplemental Content